166 related articles for article (PubMed ID: 37644546)
41. Economic burden of type 2 diabetes in Iran: A cost-of-illness study.
Jalilian H; Heydari S; Imani A; Salimi M; Mir N; Najafipour F
Health Sci Rep; 2023 Feb; 6(2):e1120. PubMed ID: 36824619
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
Oh SH; Ku H; Park KS
BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
[TBL] [Abstract][Full Text] [Related]
43. The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.
Iragorri N; de Oliveira C; Fitzgerald N; Essue B
Curr Oncol; 2021 Mar; 28(2):1216-1248. PubMed ID: 33804288
[TBL] [Abstract][Full Text] [Related]
44. Measuring the Economic Burden of Disease and Injury in Korea, 2015.
Lee YR; Cho B; Jo MW; Ock M; Lee D; Lee D; Kim MJ; Oh IH
J Korean Med Sci; 2019 Mar; 34(Suppl 1):e80. PubMed ID: 30923489
[TBL] [Abstract][Full Text] [Related]
45. Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach.
Rezaei S; Karami Matin B; Hajizadeh M; Bazyar M; Akbari Sari A
Asian Pac J Cancer Prev; 2017 Oct; 18(10):2867-2873. PubMed ID: 29072438
[TBL] [Abstract][Full Text] [Related]
46. Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province.
Ma Z; Deng G; Meng Z; Ma Y; Wu H
Int J Health Policy Manag; 2022 Sep; 11(9):1735-1743. PubMed ID: 34380200
[TBL] [Abstract][Full Text] [Related]
47. Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study.
Alshamsi S; Hamidi S; Narci HO
BMC Health Serv Res; 2022 Mar; 22(1):304. PubMed ID: 35248046
[TBL] [Abstract][Full Text] [Related]
48. Economic burden of medication-overuse headache in Iran: direct and indirect costs.
Togha M; Nadjafi-Semnani F; Martami F; Mohammadshirazi Z; Vahidpour N; Akbari-Sari A; Daroudi R
Neurol Sci; 2021 May; 42(5):1869-1877. PubMed ID: 32948933
[TBL] [Abstract][Full Text] [Related]
49. Economic burden of urgency urinary incontinence in the United States: a systematic review.
Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
[TBL] [Abstract][Full Text] [Related]
50. Economic Burden of Thalassemia Major in Iran, 2015.
Esmaeilzadeh F; Azarkeivan A; Emamgholipour S; Akbari Sari A; Yaseri M; Ahmadi B; Ghaffari M
J Res Health Sci; 2016; 16(3):111-115. PubMed ID: 27840337
[TBL] [Abstract][Full Text] [Related]
51. Economic burden of multiple sclerosis in Slovakia - from 2015 to 2020.
Babela R; Dugas J
BMC Health Serv Res; 2022 Dec; 22(1):1467. PubMed ID: 36461018
[TBL] [Abstract][Full Text] [Related]
52. Estimation of Prostate Cancer Cost in Egypt From a Societal Perspective.
Elsisi GH; El-Attar MM; Ismaeil SM; El-Shater ME; Kirollos MG; Sedrak AS; Morad H; Abdel-Mohsen H; Abdel-Aziz M; Magdy M; Loutfy O
Glob J Qual Saf Healthc; 2023 May; 6(2):33-41. PubMed ID: 37333760
[TBL] [Abstract][Full Text] [Related]
53. The Economic Burden of Hospital Costs on Families With Type 1 Diabetes Mellitus Children: The Role of Medical Insurance in Shandong Province, China.
Wang S; Guo Y; Maitland E; Nicholas S; Sun J; Leng A
Front Public Health; 2022; 10():853306. PubMed ID: 35602147
[TBL] [Abstract][Full Text] [Related]
54. The economic cost of cancer treatment in Iran.
Jabbari A; Hadian M; Mazaheri E; Jelodar ZK
J Educ Health Promot; 2023; 12():32. PubMed ID: 37034875
[TBL] [Abstract][Full Text] [Related]
55. Estimating the Economic Burden of Lung Cancer in Iran.
Rezaei S; Akbari Sari A; Woldemichael A; Soofi M; Kazemi A; Karami Matin B
Asian Pac J Cancer Prev; 2016 Oct; 17(10):4729-4733. PubMed ID: 27893204
[TBL] [Abstract][Full Text] [Related]
56. Economic Burden of Hepatitis C Virus Infection in Different Stages of Disease: A Report From Southern Iran.
Zare F; Fattahi MR; Sepehrimanesh M; Safarpour AR
Hepat Mon; 2016 Apr; 16(4):e32654. PubMed ID: 27257424
[TBL] [Abstract][Full Text] [Related]
57. The economic burden of oral cancer in Iran.
Rezapour A; Jahangiri R; Olyaeemanesh A; Kalaghchi B; Nouhi M; Nahvijou A
PLoS One; 2018; 13(9):e0203059. PubMed ID: 30260976
[TBL] [Abstract][Full Text] [Related]
58. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
[TBL] [Abstract][Full Text] [Related]
59. Economic burden of sickle cell disease in Brazil.
Silva-Pinto AC; Costa FF; Gualandro SFM; Fonseca PBB; Grindler CM; Souza Filho HCR; Bueno CT; Cançado RD
PLoS One; 2022; 17(6):e0269703. PubMed ID: 35709301
[TBL] [Abstract][Full Text] [Related]
60. The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia.
Elezbawy B; Fasseeh AN; Fouly E; Esba LCA; Al Abdulkarim H; Al-Haddab M; Al-Sheikh A; Altawil E; Al Turaiki A; Eshmawi M; Hamadah I; Tannira M; Dalle H; Aderian S; Roshdy A; Jaheen A; Hamad T; Abaza S; Kaló Z
J Med Econ; 2022; 25(1):1231-1239. PubMed ID: 36426726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
